global credit crisis, page-3

Tricop/SSV,

I don't anticipate this as a problem. As far as I know, SBN is selling to a limited number of JV partners and distributors (SiYi, Medinat, CMM, Express Diagnostics, Bioscreens etc - as listed on the website) and that these then sell to 3rd party administrators and/or end users. The majority of end-users are going to be governments and larger companies.

Some of these end-user companies may go broke - but if that hapens, they will be more than offset by rapidly growing government testing programs.

If anything, a prolonged recession is likely to be positive for many of SBN'S potential markets - if economic failure is associated with more drug consumption/alcoholism etc. Worst case would be a neutral impact in my view.